11/14
01:24 pm
glue
Form SC 13G/A Monte Rosa Therapeutics, Filed by: PRICE T ROWE ASSOCIATES INC /MD/
Low
Report
Form SC 13G/A Monte Rosa Therapeutics, Filed by: PRICE T ROWE ASSOCIATES INC /MD/
11/12
10:33 am
glue
Form SC 13G/A Monte Rosa Therapeutics, Filed by: FMR LLC
Medium
Report
Form SC 13G/A Monte Rosa Therapeutics, Filed by: FMR LLC
11/7
07:08 am
glue
Form 10-Q Monte Rosa Therapeutics, For: Sep 30
Low
Report
Form 10-Q Monte Rosa Therapeutics, For: Sep 30
11/7
07:06 am
glue
Form 8-K Monte Rosa Therapeutics, For: Nov 07
Low
Report
Form 8-K Monte Rosa Therapeutics, For: Nov 07
10/30
05:11 pm
glue
Form SC 13D/A Monte Rosa Therapeutics, Filed by: Versant Venture Capital VI, L.P.
Medium
Report
Form SC 13D/A Monte Rosa Therapeutics, Filed by: Versant Venture Capital VI, L.P.
10/30
04:36 pm
glue
Form 4 Monte Rosa Therapeutics, For: Oct 28 Filed by: Versant Vantage I GP-GP, LLC
Medium
Report
Form 4 Monte Rosa Therapeutics, For: Oct 28 Filed by: Versant Vantage I GP-GP, LLC
10/28
04:05 pm
glue
Form 144 Monte Rosa Therapeutics, Filed by: Wallace Owen B.
Low
Report
Form 144 Monte Rosa Therapeutics, Filed by: Wallace Owen B.
10/28
07:00 am
glue
Form 8-K Monte Rosa Therapeutics, For: Oct 25
High
Report
Form 8-K Monte Rosa Therapeutics, For: Oct 25
9/24
05:01 pm
glue
Form SC 13D/A Monte Rosa Therapeutics, Filed by: Versant Venture Capital VI, L.P.
Medium
Report
Form SC 13D/A Monte Rosa Therapeutics, Filed by: Versant Venture Capital VI, L.P.
9/24
04:41 pm
glue
Form 4 Monte Rosa Therapeutics, For: Sep 20 Filed by: Versant Vantage I GP-GP, LLC
Medium
Report
Form 4 Monte Rosa Therapeutics, For: Sep 20 Filed by: Versant Vantage I GP-GP, LLC
9/13
06:44 pm
glue
Form 4 Monte Rosa Therapeutics, For: Sep 11 Filed by: Versant Vantage I GP-GP, LLC
High
Report
Form 4 Monte Rosa Therapeutics, For: Sep 11 Filed by: Versant Vantage I GP-GP, LLC
9/13
04:30 pm
glue
Form 4 Monte Rosa Therapeutics, For: Sep 13 Filed by: Janku Filip
High
Report
Form 4 Monte Rosa Therapeutics, For: Sep 13 Filed by: Janku Filip